IOVA
Price
$4.04
Change
-$0.19 (-4.49%)
Updated
Jul 13 closing price
Capitalization
1.8B
23 days until earnings call
Intraday BUY SELL Signals
PVLA
Price
$146.03
Change
+$1.27 (+0.88%)
Updated
Jul 13 closing price
Capitalization
2.09B
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IOVA vs PVLA

IOVA vs PVLA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IOVA vs. PVLA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Buy and PVLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (IOVA: $4.04 vs. PVLA: $146.03)
Brand notoriety: IOVA and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 76% vs. PVLA: 29%
Market capitalization -- IOVA: $1.8B vs. PVLA: $2.09B
IOVA [@Biotechnology] is valued at $1.8B. PVLA’s [@Biotechnology] market capitalization is $2.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 0 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • IOVA’s FA Score: 0 green, 5 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IOVA and PVLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 3 TA indicator(s) are bullish while PVLA’s TA Score has 5 bullish TA indicator(s).

  • IOVA’s TA Score: 3 bullish, 4 bearish.
  • PVLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than IOVA.

Price Growth

IOVA (@Biotechnology) experienced а -3.58% price change this week, while PVLA (@Biotechnology) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

IOVA is expected to report earnings on Aug 06, 2026.

PVLA is expected to report earnings on Aug 13, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($2.09B) has a higher market cap than IOVA($1.8B). IOVA YTD gains are higher at: 47.985 vs. PVLA (39.515). PVLA has higher annual earnings (EBITDA): -42.66M vs. IOVA (-311.23M). IOVA has more cash in the bank: 313M vs. PVLA (262M). PVLA has less debt than IOVA: PVLA (584K) vs IOVA (47.8M). IOVA has higher revenues than PVLA: IOVA (286M) vs PVLA (0).
IOVAPVLAIOVA / PVLA
Capitalization1.8B2.09B86%
EBITDA-311.23M-42.66M730%
Gain YTD47.98539.515121%
P/E RatioN/A14.22-
Revenue286M0-
Total Cash313M262M119%
Total Debt47.8M584K8,185%
FUNDAMENTALS RATINGS
IOVA vs PVLA: Fundamental Ratings
IOVA
PVLA
OUTLOOK RATING
1..100
6040
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3735
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (42) in the Biotechnology industry is in the same range as PVLA (71) in the null industry. This means that IOVA’s stock grew similarly to PVLA’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PVLA (100) in the null industry. This means that IOVA’s stock grew similarly to PVLA’s over the last 12 months.

PVLA's SMR Rating (98) in the null industry is in the same range as IOVA (99) in the Biotechnology industry. This means that PVLA’s stock grew similarly to IOVA’s over the last 12 months.

PVLA's Price Growth Rating (35) in the null industry is in the same range as IOVA (37) in the Biotechnology industry. This means that PVLA’s stock grew similarly to IOVA’s over the last 12 months.

PVLA's P/E Growth Rating (11) in the null industry is significantly better than the same rating for IOVA (100) in the Biotechnology industry. This means that PVLA’s stock grew significantly faster than IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOVAPVLA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IOVA
Daily Signal:
Gain/Loss:
PVLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIZD12.47-0.08
-0.64%
VanEck BDC Income ETF
GJO24.81-0.16
-0.65%
Synthetic Fixed-Income Securities
FCPI54.22-0.39
-0.72%
Fidelity Stocks for Inflation ETF
MFSG29.75-0.53
-1.75%
MFS Active Growth ETF
SEMI38.05-1.04
-2.67%
Columbia Select Technology ETF

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+0.88%
VIR - PVLA
43%
Loosely correlated
-2.41%
DRMA - PVLA
42%
Loosely correlated
+0.75%
ARQT - PVLA
39%
Loosely correlated
-2.24%
IOVA - PVLA
38%
Loosely correlated
-4.49%
FHTX - PVLA
37%
Loosely correlated
-8.57%
More